Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBIT Margin (2020 - 2025)

iSpecimen has reported EBIT Margin over the past 6 years, most recently at 5192.87% for Q4 2025.

  • Quarterly results put EBIT Margin at 5192.87% for Q4 2025, down 479704.0% from a year ago — trailing twelve months through Dec 2025 was 465.42% (down 32843.0% YoY), and the annual figure for FY2025 was 465.42%, down 32843.0%.
  • EBIT Margin for Q4 2025 was 5192.87% at iSpecimen, down from 2655.19% in the prior quarter.
  • Over the last five years, EBIT Margin for ISPC hit a ceiling of 31.81% in Q1 2021 and a floor of 5192.87% in Q4 2025.
  • Median EBIT Margin over the past 5 years was 102.08% (2022), compared with a mean of 501.71%.
  • Biggest five-year swings in EBIT Margin: surged 14299bps in 2024 and later tumbled -479704bps in 2025.
  • iSpecimen's EBIT Margin stood at 78.26% in 2021, then grew by 8bps to 72.31% in 2022, then tumbled by -54bps to 111.49% in 2023, then crashed by -255bps to 395.83% in 2024, then tumbled by -1212bps to 5192.87% in 2025.
  • The last three reported values for EBIT Margin were 5192.87% (Q4 2025), 2655.19% (Q3 2025), and 255.41% (Q2 2025) per Business Quant data.